Halberd Revenue Growth Rates (HALB), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Halberd Corporation  (HALB)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

HALB's Revenue Growth by Quarter and Year

Halberd's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

HALB Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
4th Quarter July -
3rd Quarter April 0.00
2nd Quarter January 0.00
1st Quarter October 0.00
FY 0.00





HALB Revenue third quarter 2022 Y/Y Growth Comment
Halberd Corporation in the third quarter 2022 achieved Revenue of $ 0.00 millions compare to recorded in same quarter a year ago.

According to the results reported in the third quarter 2022, Halberd Corporation achieved the best Revenue growth in Medical Laboratories industry. While Halberd Corporation' s Revenue no change of 0% ranks overall at the positon no. in the third quarter 2022.


HALB Revenue ( Y/Y Growth %) 2022
 2021 2020 2019
4th Quarter July - - - -
3rd Quarter April - - - -
2nd Quarter January - - - -
1st Quarter October - - - -
FY   - - - -

Financial Statements
Halberd's third quarter 2022 Revenue $ 0.00 millions HALB's Income Statement
Halberd's third quarter 2021 Revenue $ 0.00 millions Quarterly HALB's Income Statement


HALB Revenue (Quarter on Quarter Growth %)

 2022
 2021 2020 2019
4th Quarter July - - - -
3rd Quarter April - - - -
2nd Quarter January - - - -
1st Quarter October - - - -
FY (Year on Year)   - - - -


Back to HALB Growth rate Comparisons >> Back to HALB Growth rate Comparisons >>


Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Halberd's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


HALB's III. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


HALB's III. Quarter Q/Q Revenue Comment


Halberd's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Apr 30 2022)		 12 Months Ending
 12 Months Ending
 12 Months Ending
 12 Months Ending
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment
In the Apr 30 2022 period, Halberd's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Halberd Corporation achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Apr 30 2022 period, Halberd's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Halberd Corporation achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 






Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
HALB's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue no change for the quarter ending Apr 30 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Apr 30 2022
Medtronic Plc-1.21%$ -1.209 millions
National Vision Holdings Inc -1.21%$ -1.211 millions
Ortho Clinical Diagnostics Holdings Plc-1.32%$ -1.322 millions
Revvity Inc-3.69%$ -3.689 millions
Envista Holdings Corporation-10.97%$ -10.970 millions
Lakeland Industries Inc -19.99%$ -19.987 millions
Enzo Biochem Inc-20.05%$ -20.048 millions
Ayala Pharmaceuticals Inc -81.82%$ -81.818 millions
Rafael Holdings Inc-92.32%$ -92.323 millions


About Halberd Revenue Growth Rates (HALB), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Halberd Corp (CIK 1458631).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001477932-22-008279
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Halberd Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.